Obstructive sleep apnea

ascletis-highlights-promising-glp-1-dosing-mineralys-phase-2-falls-short

Ascletis Highlights Promising GLP-1 Dosing; Mineralys Phase 2 Falls Short

Editorial 10 March, 2026

Ascletis Pharmaceuticals has reported promising data regarding its quarterly dosing regimen for GLP-1, a...

treating-sleep-apnea-could-significantly-lower-parkinson-s-risk

Treating Sleep Apnea Could Significantly Lower Parkinson’s Risk

Editorial 5 January, 2026

Research published in November 2023 reveals that untreated obstructive sleep apnea nearly doubles the...

innovative-inap-device-offers-new-hope-for-sleep-apnea-treatment

Innovative iNAP Device Offers New Hope for Sleep Apnea Treatment

Editorial 11 July, 2025

Obstructive sleep apnea (OSA) remains one of the most common sleep-related breathing disorders, affecting...